Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 24.47 USD 2.47% Market Closed
Market Cap: 1.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc

Wall Street analysts forecast AMPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPH is 35.96 USD with a low forecast of 31.31 USD and a high forecast of 42 USD.

AMPH Lowest Forecast
Wall Street Target
31.31 USD
28% Upside
AMPH Average Forecast
Wall Street Target
35.96 USD
47% Upside
AMPH Highest Forecast
Wall Street Target
42 USD
72% Upside
Lowest
Price Target
31.31 USD
28% Upside
Average
Price Target
35.96 USD
47% Upside
Highest
Price Target
42 USD
72% Upside
Amphastar Pharmaceuticals Inc Competitors:
Price Targets
AMIORG
Ami Organics Ltd
9% Upside
FULC
Fulcrum Therapeutics Inc
23% Upside
TBPH
Theravance Biopharma Inc
21% Upside
P
PLTH
Planet 13 Holdings Inc
156% Upside
AMIORG
Ami Organics Ltd
9% Upside
FULC
Fulcrum Therapeutics Inc
23% Upside
TBPH
Theravance Biopharma Inc
21% Upside
P
PLTH
Planet 13 Holdings Inc
156% Upside
4503
Astellas Pharma Inc
28% Upside
M
MAZE
Maze Therapeutics Inc
126% Upside
SUVENPHAR
Suven Pharmaceuticals Ltd
27% Upside
CRON
Cronos Group Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 4%.

14%
Past Growth
4%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's operating income is 38%. The projected CAGR for the next 3 years is 11%.

38%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 5%.

42%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
AMPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMPH stock valuation using valuation multiples.
Wall Street Estimates
AMPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMPH's stock price target?
Price Target
35.96 USD

According to Wall Street analysts, the average 1-year price target for AMPH is 35.96 USD with a low forecast of 31.31 USD and a high forecast of 42 USD.

What is Amphastar Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 4%.

What is Amphastar Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's operating income is 38%. The projected CAGR for the next 3 years is 11%.

What is Amphastar Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 5%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.